|
|
Post by goyocafe on Nov 10, 2016 11:21:41 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 10, 2016 11:29:59 GMT -5
did you read the article? TypeZero’s inControl closed loop algorithm - Do you know what closed loop is ? no manual intervention unless you can find a way for Afrezza to be puffed automatically. In a not so closed loop, it was done. perhaps you were not aware. www.youtube.com/watch?v=GGgGjtM5ipg |
|
|
|
Post by goyocafe on Nov 10, 2016 11:35:12 GMT -5
did you read the article? TypeZero’s inControl closed loop algorithm - Do you know what closed loop is ? no manual intervention unless you can find a way for Afrezza to be puffed automatically. In a not so closed loop, it was done. perhaps you were not aware. www.youtube.com/watch?v=GGgGjtM5ipgI guess I was thinking that they should recognize after the Sansum results that closed loop may not yield optimal results, so why not embrace a solution that yields best results for PWDs. |
|
|
|
Post by mannmade on Nov 10, 2016 11:36:46 GMT -5
But remember, AFREZZA was used at the Samsun trials for the AP and that has yet to be really made known. Once the AP is on the market and people who use it realize that you still need to bolus for meals, AFREZZA should get a boost.. Along with increased cgm market penetration. Think of AFREZZA as a digital or technological advancement in insulin because it is the only insulin able to react in real time which is what all of the new digital/technology pushes are driving in medicine right now.
I believe that pumps will get phased out and more diabetics will switch to a cgm plus basal (tresiba) and AFREZZA. Just as good if not better than an AP, less expensive, fewer moving parts, no batteries and less invasive to the body.
|
|
